Our findings underscore NAT10’s oncogenic role in promoting glycolysis-immunosuppression crosstalk within cancer cells [11] and show that NAT10-induced NPM1 acetylation enhances PD-L1 transcription and expression, strengthening immune evasion [36]. The gene discussed is CD274; the disease is cancer.